Discovery of <i>N</i>,4-Di(1<i>H</i>-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation
Cyclin-dependent kinase 2 (CDK2) has been garnering considerable interest as a target to develop new cancer treatments and to ameliorate resistance to CDK4/6 inhibitors. However, a selective CDK2 inhibitor has yet to be clinically approved. With the desire to discover novel, potent, and selective CD...
Main Authors: | Biruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo, Lianmeng Kou, Laychiluh Mekonnen, Yuchao Yang, Sunita K. C. Basnet, Ramin Hassankhani, Matthew J. Sykes, Mingfeng Yu, Shudong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/7/2951 |
Similar Items
-
Synthesis and In Vitro Anticancer Activity of Novel 4-Aryl-3-(4-methoxyphenyl)-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridines Arrest Cell Cycle and Induce Cell Apoptosis by Inhibiting CDK2 and/or CDK9
by: Basma S. Almansour, et al.
Published: (2023-09-01) -
Insights into the Peritumoural Brain Zone of Glioblastoma: <i>CDK4</i> and <i>EXT2</i> May Be Potential Drivers of Malignancy
by: Martina Giambra, et al.
Published: (2023-02-01) -
Synthesis and Diels–Alder Reactivity of 4-Fluoro-4-Methyl-4<i>H</i>-Pyrazoles
by: Nile S. Abularrage, et al.
Published: (2020-05-01) -
4-[(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl]-4-methyl-2-phenyl-4,5-dihydrooxazole
by: Sara Hajib, et al.
Published: (2019-07-01) -
Synthesis and Characterization of Novel 2-(1,2,3-Triazol-4-yl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl)thiazoles and 2-(4,5-Dihydro-1<i>H</i>-pyrazol-1-yl)-4-(1<i>H</i>-1,2,3-triazol-4-yl)thiazoles
by: Benson M. Kariuki, et al.
Published: (2022-12-01)